Champions Oncology Announces Agreement with Weill Cornell Medicine [Yahoo! Finance]
Champions Oncology, Inc. (CSBR)
NASDAQ:AMEX Investor Relations:
championsoncology.com/investors
Company Research
Source: Yahoo! Finance
HACKENSACK, NJ / ACCESSWIRE / October 16, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, is pleased to announce a licensing agreement with Weill Cornell Medicine through the Center for Technology Licensing (CTL), part of Enterprise Innovation at Weill Cornell Medicine. This strategic collaboration will allow Champions Oncology to distribute and commercialize Weill Cornell Medicine's extensive bank of hematological patient-derived xenograft (PDX) models, generated by Dr. Giorgio Inghirami, Professor of Pathology and Laboratory Medicine at the institution and a member of the Englander Institute for Precision Medicine and Sandra and Edward Meyer Cancer Center. Through this agreement, Champions Oncology will hold exclusive rights, for a limited time, to offer services leveraging Weill Cornell Medicine's models, and will serve as a repository to distribute these models to academic institutions worldwide. This collab
Show less
Read more
Impact Snapshot
Event Time:
CSBR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CSBR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CSBR alerts
High impacting Champions Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
CSBR
News
- Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- Champions Oncology Announces Agreement with Weill Cornell MedicineAccesswire
- Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business [Yahoo! Finance]Yahoo! Finance
- Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million [Yahoo! Finance]Yahoo! Finance
CSBR
Earnings
- 12/12/23 - Beat
CSBR
Sec Filings
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- CSBR's page on the SEC website